This suggests that CE inclusion is not always linked robustly with TDP-43 aggregation, and/or the “window” of detectable pTDP-43 pathology does not represent fully the TDP-43 dysregulation in the brain. The gene discussed is TARDBP; the disease is cholesteryl ester measurement.